Service & Software
Global IVD CDMO Market Research Report 2025
- Jul 28, 25
- ID: 406842
- Pages: 92
- Figures: 98
- Views: 4
The global market for IVD CDMO was valued at US$ 17685 million in the year 2024 and is projected to reach a revised size of US$ 34379 million by 2031, growing at a CAGR of 10.3% during the forecast period.
IVD CDMO (Contract Development and Manufacturing Organization) refers to a professional outsourcing service organization that focuses on providing R&D, process development, manufacturing and quality compliance support for in vitro diagnostic products (such as reagents, consumables, instruments, etc.). It provides diagnostic companies, start-ups or brands with one-stop solutions from concept design, raw material screening, formula development, sample trial production to large-scale production, packaging, registration support, etc., helping customers reduce R&D and production costs and speed up the product launch process. It is especially widely used in sub-sectors such as molecular diagnosis, immunodiagnosis and POCT.
North American market for IVD CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for IVD CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for IVD CDMO in Instruments is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of IVD CDMO include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut, Erreka, GBC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVD CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD CDMO.
The IVD CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IVD CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hitachi
Canon
TE Connectivity
JEOL
HU Group
DCN DX
Stevanato
Argonaut
Erreka
GBC
Phillips Medisize
AIVD Biotech
Kaishi Biological Technology
Keysmile Biological Technology
Nabai Medical Technology
Hochuen Medical
Segment by Type
Molecular Diagnosis
Immunodiagnosis
Biochemical Diagnosis
Other
Segment by Application
Instruments
Consumables
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
IVD CDMO (Contract Development and Manufacturing Organization) refers to a professional outsourcing service organization that focuses on providing R&D, process development, manufacturing and quality compliance support for in vitro diagnostic products (such as reagents, consumables, instruments, etc.). It provides diagnostic companies, start-ups or brands with one-stop solutions from concept design, raw material screening, formula development, sample trial production to large-scale production, packaging, registration support, etc., helping customers reduce R&D and production costs and speed up the product launch process. It is especially widely used in sub-sectors such as molecular diagnosis, immunodiagnosis and POCT.
North American market for IVD CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for IVD CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for IVD CDMO in Instruments is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of IVD CDMO include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut, Erreka, GBC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVD CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD CDMO.
The IVD CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IVD CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hitachi
Canon
TE Connectivity
JEOL
HU Group
DCN DX
Stevanato
Argonaut
Erreka
GBC
Phillips Medisize
AIVD Biotech
Kaishi Biological Technology
Keysmile Biological Technology
Nabai Medical Technology
Hochuen Medical
Segment by Type
Molecular Diagnosis
Immunodiagnosis
Biochemical Diagnosis
Other
Segment by Application
Instruments
Consumables
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnosis
1.2.3 Immunodiagnosis
1.2.4 Biochemical Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global IVD CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Instruments
1.3.3 Consumables
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD CDMO Market Perspective (2020-2031)
2.2 Global IVD CDMO Growth Trends by Region
2.2.1 Global IVD CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IVD CDMO Historic Market Size by Region (2020-2025)
2.2.3 IVD CDMO Forecasted Market Size by Region (2026-2031)
2.3 IVD CDMO Market Dynamics
2.3.1 IVD CDMO Industry Trends
2.3.2 IVD CDMO Market Drivers
2.3.3 IVD CDMO Market Challenges
2.3.4 IVD CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD CDMO Players by Revenue
3.1.1 Global Top IVD CDMO Players by Revenue (2020-2025)
3.1.2 Global IVD CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top IVD CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IVD CDMO Revenue
3.4 Global IVD CDMO Market Concentration Ratio
3.4.1 Global IVD CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD CDMO Revenue in 2024
3.5 Global Key Players of IVD CDMO Head office and Area Served
3.6 Global Key Players of IVD CDMO, Product and Application
3.7 Global Key Players of IVD CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD CDMO Breakdown Data by Type
4.1 Global IVD CDMO Historic Market Size by Type (2020-2025)
4.2 Global IVD CDMO Forecasted Market Size by Type (2026-2031)
5 IVD CDMO Breakdown Data by Application
5.1 Global IVD CDMO Historic Market Size by Application (2020-2025)
5.2 Global IVD CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IVD CDMO Market Size (2020-2031)
6.2 North America IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IVD CDMO Market Size by Country (2020-2025)
6.4 North America IVD CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD CDMO Market Size (2020-2031)
7.2 Europe IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IVD CDMO Market Size by Country (2020-2025)
7.4 Europe IVD CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific IVD CDMO Market Size (2020-2031)
8.2 Asia-Pacific IVD CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IVD CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific IVD CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America IVD CDMO Market Size (2020-2031)
9.2 Latin America IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IVD CDMO Market Size by Country (2020-2025)
9.4 Latin America IVD CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD CDMO Market Size (2020-2031)
10.2 Middle East & Africa IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IVD CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa IVD CDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hitachi
11.1.1 Hitachi Company Details
11.1.2 Hitachi Business Overview
11.1.3 Hitachi IVD CDMO Introduction
11.1.4 Hitachi Revenue in IVD CDMO Business (2020-2025)
11.1.5 Hitachi Recent Development
11.2 Canon
11.2.1 Canon Company Details
11.2.2 Canon Business Overview
11.2.3 Canon IVD CDMO Introduction
11.2.4 Canon Revenue in IVD CDMO Business (2020-2025)
11.2.5 Canon Recent Development
11.3 TE Connectivity
11.3.1 TE Connectivity Company Details
11.3.2 TE Connectivity Business Overview
11.3.3 TE Connectivity IVD CDMO Introduction
11.3.4 TE Connectivity Revenue in IVD CDMO Business (2020-2025)
11.3.5 TE Connectivity Recent Development
11.4 JEOL
11.4.1 JEOL Company Details
11.4.2 JEOL Business Overview
11.4.3 JEOL IVD CDMO Introduction
11.4.4 JEOL Revenue in IVD CDMO Business (2020-2025)
11.4.5 JEOL Recent Development
11.5 HU Group
11.5.1 HU Group Company Details
11.5.2 HU Group Business Overview
11.5.3 HU Group IVD CDMO Introduction
11.5.4 HU Group Revenue in IVD CDMO Business (2020-2025)
11.5.5 HU Group Recent Development
11.6 DCN DX
11.6.1 DCN DX Company Details
11.6.2 DCN DX Business Overview
11.6.3 DCN DX IVD CDMO Introduction
11.6.4 DCN DX Revenue in IVD CDMO Business (2020-2025)
11.6.5 DCN DX Recent Development
11.7 Stevanato
11.7.1 Stevanato Company Details
11.7.2 Stevanato Business Overview
11.7.3 Stevanato IVD CDMO Introduction
11.7.4 Stevanato Revenue in IVD CDMO Business (2020-2025)
11.7.5 Stevanato Recent Development
11.8 Argonaut
11.8.1 Argonaut Company Details
11.8.2 Argonaut Business Overview
11.8.3 Argonaut IVD CDMO Introduction
11.8.4 Argonaut Revenue in IVD CDMO Business (2020-2025)
11.8.5 Argonaut Recent Development
11.9 Erreka
11.9.1 Erreka Company Details
11.9.2 Erreka Business Overview
11.9.3 Erreka IVD CDMO Introduction
11.9.4 Erreka Revenue in IVD CDMO Business (2020-2025)
11.9.5 Erreka Recent Development
11.10 GBC
11.10.1 GBC Company Details
11.10.2 GBC Business Overview
11.10.3 GBC IVD CDMO Introduction
11.10.4 GBC Revenue in IVD CDMO Business (2020-2025)
11.10.5 GBC Recent Development
11.11 Phillips Medisize
11.11.1 Phillips Medisize Company Details
11.11.2 Phillips Medisize Business Overview
11.11.3 Phillips Medisize IVD CDMO Introduction
11.11.4 Phillips Medisize Revenue in IVD CDMO Business (2020-2025)
11.11.5 Phillips Medisize Recent Development
11.12 AIVD Biotech
11.12.1 AIVD Biotech Company Details
11.12.2 AIVD Biotech Business Overview
11.12.3 AIVD Biotech IVD CDMO Introduction
11.12.4 AIVD Biotech Revenue in IVD CDMO Business (2020-2025)
11.12.5 AIVD Biotech Recent Development
11.13 Kaishi Biological Technology
11.13.1 Kaishi Biological Technology Company Details
11.13.2 Kaishi Biological Technology Business Overview
11.13.3 Kaishi Biological Technology IVD CDMO Introduction
11.13.4 Kaishi Biological Technology Revenue in IVD CDMO Business (2020-2025)
11.13.5 Kaishi Biological Technology Recent Development
11.14 Keysmile Biological Technology
11.14.1 Keysmile Biological Technology Company Details
11.14.2 Keysmile Biological Technology Business Overview
11.14.3 Keysmile Biological Technology IVD CDMO Introduction
11.14.4 Keysmile Biological Technology Revenue in IVD CDMO Business (2020-2025)
11.14.5 Keysmile Biological Technology Recent Development
11.15 Nabai Medical Technology
11.15.1 Nabai Medical Technology Company Details
11.15.2 Nabai Medical Technology Business Overview
11.15.3 Nabai Medical Technology IVD CDMO Introduction
11.15.4 Nabai Medical Technology Revenue in IVD CDMO Business (2020-2025)
11.15.5 Nabai Medical Technology Recent Development
11.16 Hochuen Medical
11.16.1 Hochuen Medical Company Details
11.16.2 Hochuen Medical Business Overview
11.16.3 Hochuen Medical IVD CDMO Introduction
11.16.4 Hochuen Medical Revenue in IVD CDMO Business (2020-2025)
11.16.5 Hochuen Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnosis
1.2.3 Immunodiagnosis
1.2.4 Biochemical Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global IVD CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Instruments
1.3.3 Consumables
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD CDMO Market Perspective (2020-2031)
2.2 Global IVD CDMO Growth Trends by Region
2.2.1 Global IVD CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IVD CDMO Historic Market Size by Region (2020-2025)
2.2.3 IVD CDMO Forecasted Market Size by Region (2026-2031)
2.3 IVD CDMO Market Dynamics
2.3.1 IVD CDMO Industry Trends
2.3.2 IVD CDMO Market Drivers
2.3.3 IVD CDMO Market Challenges
2.3.4 IVD CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD CDMO Players by Revenue
3.1.1 Global Top IVD CDMO Players by Revenue (2020-2025)
3.1.2 Global IVD CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top IVD CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IVD CDMO Revenue
3.4 Global IVD CDMO Market Concentration Ratio
3.4.1 Global IVD CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD CDMO Revenue in 2024
3.5 Global Key Players of IVD CDMO Head office and Area Served
3.6 Global Key Players of IVD CDMO, Product and Application
3.7 Global Key Players of IVD CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD CDMO Breakdown Data by Type
4.1 Global IVD CDMO Historic Market Size by Type (2020-2025)
4.2 Global IVD CDMO Forecasted Market Size by Type (2026-2031)
5 IVD CDMO Breakdown Data by Application
5.1 Global IVD CDMO Historic Market Size by Application (2020-2025)
5.2 Global IVD CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IVD CDMO Market Size (2020-2031)
6.2 North America IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IVD CDMO Market Size by Country (2020-2025)
6.4 North America IVD CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD CDMO Market Size (2020-2031)
7.2 Europe IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IVD CDMO Market Size by Country (2020-2025)
7.4 Europe IVD CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific IVD CDMO Market Size (2020-2031)
8.2 Asia-Pacific IVD CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IVD CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific IVD CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America IVD CDMO Market Size (2020-2031)
9.2 Latin America IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IVD CDMO Market Size by Country (2020-2025)
9.4 Latin America IVD CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD CDMO Market Size (2020-2031)
10.2 Middle East & Africa IVD CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IVD CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa IVD CDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hitachi
11.1.1 Hitachi Company Details
11.1.2 Hitachi Business Overview
11.1.3 Hitachi IVD CDMO Introduction
11.1.4 Hitachi Revenue in IVD CDMO Business (2020-2025)
11.1.5 Hitachi Recent Development
11.2 Canon
11.2.1 Canon Company Details
11.2.2 Canon Business Overview
11.2.3 Canon IVD CDMO Introduction
11.2.4 Canon Revenue in IVD CDMO Business (2020-2025)
11.2.5 Canon Recent Development
11.3 TE Connectivity
11.3.1 TE Connectivity Company Details
11.3.2 TE Connectivity Business Overview
11.3.3 TE Connectivity IVD CDMO Introduction
11.3.4 TE Connectivity Revenue in IVD CDMO Business (2020-2025)
11.3.5 TE Connectivity Recent Development
11.4 JEOL
11.4.1 JEOL Company Details
11.4.2 JEOL Business Overview
11.4.3 JEOL IVD CDMO Introduction
11.4.4 JEOL Revenue in IVD CDMO Business (2020-2025)
11.4.5 JEOL Recent Development
11.5 HU Group
11.5.1 HU Group Company Details
11.5.2 HU Group Business Overview
11.5.3 HU Group IVD CDMO Introduction
11.5.4 HU Group Revenue in IVD CDMO Business (2020-2025)
11.5.5 HU Group Recent Development
11.6 DCN DX
11.6.1 DCN DX Company Details
11.6.2 DCN DX Business Overview
11.6.3 DCN DX IVD CDMO Introduction
11.6.4 DCN DX Revenue in IVD CDMO Business (2020-2025)
11.6.5 DCN DX Recent Development
11.7 Stevanato
11.7.1 Stevanato Company Details
11.7.2 Stevanato Business Overview
11.7.3 Stevanato IVD CDMO Introduction
11.7.4 Stevanato Revenue in IVD CDMO Business (2020-2025)
11.7.5 Stevanato Recent Development
11.8 Argonaut
11.8.1 Argonaut Company Details
11.8.2 Argonaut Business Overview
11.8.3 Argonaut IVD CDMO Introduction
11.8.4 Argonaut Revenue in IVD CDMO Business (2020-2025)
11.8.5 Argonaut Recent Development
11.9 Erreka
11.9.1 Erreka Company Details
11.9.2 Erreka Business Overview
11.9.3 Erreka IVD CDMO Introduction
11.9.4 Erreka Revenue in IVD CDMO Business (2020-2025)
11.9.5 Erreka Recent Development
11.10 GBC
11.10.1 GBC Company Details
11.10.2 GBC Business Overview
11.10.3 GBC IVD CDMO Introduction
11.10.4 GBC Revenue in IVD CDMO Business (2020-2025)
11.10.5 GBC Recent Development
11.11 Phillips Medisize
11.11.1 Phillips Medisize Company Details
11.11.2 Phillips Medisize Business Overview
11.11.3 Phillips Medisize IVD CDMO Introduction
11.11.4 Phillips Medisize Revenue in IVD CDMO Business (2020-2025)
11.11.5 Phillips Medisize Recent Development
11.12 AIVD Biotech
11.12.1 AIVD Biotech Company Details
11.12.2 AIVD Biotech Business Overview
11.12.3 AIVD Biotech IVD CDMO Introduction
11.12.4 AIVD Biotech Revenue in IVD CDMO Business (2020-2025)
11.12.5 AIVD Biotech Recent Development
11.13 Kaishi Biological Technology
11.13.1 Kaishi Biological Technology Company Details
11.13.2 Kaishi Biological Technology Business Overview
11.13.3 Kaishi Biological Technology IVD CDMO Introduction
11.13.4 Kaishi Biological Technology Revenue in IVD CDMO Business (2020-2025)
11.13.5 Kaishi Biological Technology Recent Development
11.14 Keysmile Biological Technology
11.14.1 Keysmile Biological Technology Company Details
11.14.2 Keysmile Biological Technology Business Overview
11.14.3 Keysmile Biological Technology IVD CDMO Introduction
11.14.4 Keysmile Biological Technology Revenue in IVD CDMO Business (2020-2025)
11.14.5 Keysmile Biological Technology Recent Development
11.15 Nabai Medical Technology
11.15.1 Nabai Medical Technology Company Details
11.15.2 Nabai Medical Technology Business Overview
11.15.3 Nabai Medical Technology IVD CDMO Introduction
11.15.4 Nabai Medical Technology Revenue in IVD CDMO Business (2020-2025)
11.15.5 Nabai Medical Technology Recent Development
11.16 Hochuen Medical
11.16.1 Hochuen Medical Company Details
11.16.2 Hochuen Medical Business Overview
11.16.3 Hochuen Medical IVD CDMO Introduction
11.16.4 Hochuen Medical Revenue in IVD CDMO Business (2020-2025)
11.16.5 Hochuen Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global IVD CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Diagnosis
Table 3. Key Players of Immunodiagnosis
Table 4. Key Players of Biochemical Diagnosis
Table 5. Key Players of Other
Table 6. Global IVD CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global IVD CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global IVD CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global IVD CDMO Market Share by Region (2020-2025)
Table 10. Global IVD CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global IVD CDMO Market Share by Region (2026-2031)
Table 12. IVD CDMO Market Trends
Table 13. IVD CDMO Market Drivers
Table 14. IVD CDMO Market Challenges
Table 15. IVD CDMO Market Restraints
Table 16. Global IVD CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global IVD CDMO Market Share by Players (2020-2025)
Table 18. Global Top IVD CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD CDMO as of 2024)
Table 19. Ranking of Global Top IVD CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by IVD CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of IVD CDMO, Headquarters and Area Served
Table 22. Global Key Players of IVD CDMO, Product and Application
Table 23. Global Key Players of IVD CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global IVD CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global IVD CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global IVD CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global IVD CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global IVD CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global IVD CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global IVD CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global IVD CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific IVD CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific IVD CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific IVD CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Hitachi Company Details
Table 49. Hitachi Business Overview
Table 50. Hitachi IVD CDMO Product
Table 51. Hitachi Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 52. Hitachi Recent Development
Table 53. Canon Company Details
Table 54. Canon Business Overview
Table 55. Canon IVD CDMO Product
Table 56. Canon Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 57. Canon Recent Development
Table 58. TE Connectivity Company Details
Table 59. TE Connectivity Business Overview
Table 60. TE Connectivity IVD CDMO Product
Table 61. TE Connectivity Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 62. TE Connectivity Recent Development
Table 63. JEOL Company Details
Table 64. JEOL Business Overview
Table 65. JEOL IVD CDMO Product
Table 66. JEOL Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 67. JEOL Recent Development
Table 68. HU Group Company Details
Table 69. HU Group Business Overview
Table 70. HU Group IVD CDMO Product
Table 71. HU Group Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 72. HU Group Recent Development
Table 73. DCN DX Company Details
Table 74. DCN DX Business Overview
Table 75. DCN DX IVD CDMO Product
Table 76. DCN DX Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 77. DCN DX Recent Development
Table 78. Stevanato Company Details
Table 79. Stevanato Business Overview
Table 80. Stevanato IVD CDMO Product
Table 81. Stevanato Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 82. Stevanato Recent Development
Table 83. Argonaut Company Details
Table 84. Argonaut Business Overview
Table 85. Argonaut IVD CDMO Product
Table 86. Argonaut Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 87. Argonaut Recent Development
Table 88. Erreka Company Details
Table 89. Erreka Business Overview
Table 90. Erreka IVD CDMO Product
Table 91. Erreka Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 92. Erreka Recent Development
Table 93. GBC Company Details
Table 94. GBC Business Overview
Table 95. GBC IVD CDMO Product
Table 96. GBC Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 97. GBC Recent Development
Table 98. Phillips Medisize Company Details
Table 99. Phillips Medisize Business Overview
Table 100. Phillips Medisize IVD CDMO Product
Table 101. Phillips Medisize Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 102. Phillips Medisize Recent Development
Table 103. AIVD Biotech Company Details
Table 104. AIVD Biotech Business Overview
Table 105. AIVD Biotech IVD CDMO Product
Table 106. AIVD Biotech Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 107. AIVD Biotech Recent Development
Table 108. Kaishi Biological Technology Company Details
Table 109. Kaishi Biological Technology Business Overview
Table 110. Kaishi Biological Technology IVD CDMO Product
Table 111. Kaishi Biological Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 112. Kaishi Biological Technology Recent Development
Table 113. Keysmile Biological Technology Company Details
Table 114. Keysmile Biological Technology Business Overview
Table 115. Keysmile Biological Technology IVD CDMO Product
Table 116. Keysmile Biological Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 117. Keysmile Biological Technology Recent Development
Table 118. Nabai Medical Technology Company Details
Table 119. Nabai Medical Technology Business Overview
Table 120. Nabai Medical Technology IVD CDMO Product
Table 121. Nabai Medical Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 122. Nabai Medical Technology Recent Development
Table 123. Hochuen Medical Company Details
Table 124. Hochuen Medical Business Overview
Table 125. Hochuen Medical IVD CDMO Product
Table 126. Hochuen Medical Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 127. Hochuen Medical Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. IVD CDMO Picture
Figure 2. Global IVD CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global IVD CDMO Market Share by Type: 2024 VS 2031
Figure 4. Molecular Diagnosis Features
Figure 5. Immunodiagnosis Features
Figure 6. Biochemical Diagnosis Features
Figure 7. Other Features
Figure 8. Global IVD CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global IVD CDMO Market Share by Application: 2024 VS 2031
Figure 10. Instruments Case Studies
Figure 11. Consumables Case Studies
Figure 12. IVD CDMO Report Years Considered
Figure 13. Global IVD CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global IVD CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global IVD CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global IVD CDMO Market Share by Players in 2024
Figure 17. Global IVD CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by IVD CDMO Revenue in 2024
Figure 19. North America IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America IVD CDMO Market Share by Country (2020-2031)
Figure 21. United States IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe IVD CDMO Market Share by Country (2020-2031)
Figure 25. Germany IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific IVD CDMO Market Share by Region (2020-2031)
Figure 33. China IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America IVD CDMO Market Share by Country (2020-2031)
Figure 41. Mexico IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa IVD CDMO Market Share by Country (2020-2031)
Figure 45. Israel IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hitachi Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 49. Canon Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 50. TE Connectivity Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 51. JEOL Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 52. HU Group Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 53. DCN DX Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 54. Stevanato Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 55. Argonaut Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 56. Erreka Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 57. GBC Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 58. Phillips Medisize Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 59. AIVD Biotech Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 60. Kaishi Biological Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 61. Keysmile Biological Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 62. Nabai Medical Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 63. Hochuen Medical Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global IVD CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Diagnosis
Table 3. Key Players of Immunodiagnosis
Table 4. Key Players of Biochemical Diagnosis
Table 5. Key Players of Other
Table 6. Global IVD CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global IVD CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global IVD CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global IVD CDMO Market Share by Region (2020-2025)
Table 10. Global IVD CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global IVD CDMO Market Share by Region (2026-2031)
Table 12. IVD CDMO Market Trends
Table 13. IVD CDMO Market Drivers
Table 14. IVD CDMO Market Challenges
Table 15. IVD CDMO Market Restraints
Table 16. Global IVD CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global IVD CDMO Market Share by Players (2020-2025)
Table 18. Global Top IVD CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD CDMO as of 2024)
Table 19. Ranking of Global Top IVD CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by IVD CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of IVD CDMO, Headquarters and Area Served
Table 22. Global Key Players of IVD CDMO, Product and Application
Table 23. Global Key Players of IVD CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global IVD CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global IVD CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global IVD CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global IVD CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global IVD CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global IVD CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global IVD CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global IVD CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific IVD CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific IVD CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific IVD CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa IVD CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa IVD CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa IVD CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Hitachi Company Details
Table 49. Hitachi Business Overview
Table 50. Hitachi IVD CDMO Product
Table 51. Hitachi Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 52. Hitachi Recent Development
Table 53. Canon Company Details
Table 54. Canon Business Overview
Table 55. Canon IVD CDMO Product
Table 56. Canon Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 57. Canon Recent Development
Table 58. TE Connectivity Company Details
Table 59. TE Connectivity Business Overview
Table 60. TE Connectivity IVD CDMO Product
Table 61. TE Connectivity Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 62. TE Connectivity Recent Development
Table 63. JEOL Company Details
Table 64. JEOL Business Overview
Table 65. JEOL IVD CDMO Product
Table 66. JEOL Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 67. JEOL Recent Development
Table 68. HU Group Company Details
Table 69. HU Group Business Overview
Table 70. HU Group IVD CDMO Product
Table 71. HU Group Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 72. HU Group Recent Development
Table 73. DCN DX Company Details
Table 74. DCN DX Business Overview
Table 75. DCN DX IVD CDMO Product
Table 76. DCN DX Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 77. DCN DX Recent Development
Table 78. Stevanato Company Details
Table 79. Stevanato Business Overview
Table 80. Stevanato IVD CDMO Product
Table 81. Stevanato Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 82. Stevanato Recent Development
Table 83. Argonaut Company Details
Table 84. Argonaut Business Overview
Table 85. Argonaut IVD CDMO Product
Table 86. Argonaut Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 87. Argonaut Recent Development
Table 88. Erreka Company Details
Table 89. Erreka Business Overview
Table 90. Erreka IVD CDMO Product
Table 91. Erreka Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 92. Erreka Recent Development
Table 93. GBC Company Details
Table 94. GBC Business Overview
Table 95. GBC IVD CDMO Product
Table 96. GBC Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 97. GBC Recent Development
Table 98. Phillips Medisize Company Details
Table 99. Phillips Medisize Business Overview
Table 100. Phillips Medisize IVD CDMO Product
Table 101. Phillips Medisize Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 102. Phillips Medisize Recent Development
Table 103. AIVD Biotech Company Details
Table 104. AIVD Biotech Business Overview
Table 105. AIVD Biotech IVD CDMO Product
Table 106. AIVD Biotech Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 107. AIVD Biotech Recent Development
Table 108. Kaishi Biological Technology Company Details
Table 109. Kaishi Biological Technology Business Overview
Table 110. Kaishi Biological Technology IVD CDMO Product
Table 111. Kaishi Biological Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 112. Kaishi Biological Technology Recent Development
Table 113. Keysmile Biological Technology Company Details
Table 114. Keysmile Biological Technology Business Overview
Table 115. Keysmile Biological Technology IVD CDMO Product
Table 116. Keysmile Biological Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 117. Keysmile Biological Technology Recent Development
Table 118. Nabai Medical Technology Company Details
Table 119. Nabai Medical Technology Business Overview
Table 120. Nabai Medical Technology IVD CDMO Product
Table 121. Nabai Medical Technology Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 122. Nabai Medical Technology Recent Development
Table 123. Hochuen Medical Company Details
Table 124. Hochuen Medical Business Overview
Table 125. Hochuen Medical IVD CDMO Product
Table 126. Hochuen Medical Revenue in IVD CDMO Business (2020-2025) & (US$ Million)
Table 127. Hochuen Medical Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. IVD CDMO Picture
Figure 2. Global IVD CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global IVD CDMO Market Share by Type: 2024 VS 2031
Figure 4. Molecular Diagnosis Features
Figure 5. Immunodiagnosis Features
Figure 6. Biochemical Diagnosis Features
Figure 7. Other Features
Figure 8. Global IVD CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global IVD CDMO Market Share by Application: 2024 VS 2031
Figure 10. Instruments Case Studies
Figure 11. Consumables Case Studies
Figure 12. IVD CDMO Report Years Considered
Figure 13. Global IVD CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global IVD CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global IVD CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global IVD CDMO Market Share by Players in 2024
Figure 17. Global IVD CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by IVD CDMO Revenue in 2024
Figure 19. North America IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America IVD CDMO Market Share by Country (2020-2031)
Figure 21. United States IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe IVD CDMO Market Share by Country (2020-2031)
Figure 25. Germany IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific IVD CDMO Market Share by Region (2020-2031)
Figure 33. China IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America IVD CDMO Market Share by Country (2020-2031)
Figure 41. Mexico IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa IVD CDMO Market Share by Country (2020-2031)
Figure 45. Israel IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE IVD CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hitachi Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 49. Canon Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 50. TE Connectivity Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 51. JEOL Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 52. HU Group Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 53. DCN DX Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 54. Stevanato Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 55. Argonaut Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 56. Erreka Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 57. GBC Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 58. Phillips Medisize Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 59. AIVD Biotech Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 60. Kaishi Biological Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 61. Keysmile Biological Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 62. Nabai Medical Technology Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 63. Hochuen Medical Revenue Growth Rate in IVD CDMO Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Bed Cushion Market Research Report 2025
Jul 28, 25
Global Edible Bovine Lactoferrin Market Research Report 2025
Jul 28, 25
Global Scuba BCDs Market Research Report 2025
Jul 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232